Bank of Montreal
INDV icon

Bank of Montreal’s Indivior Pharmaceuticals INDV Stock Holding History

Bank of Montreal’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$287K Buy
9,410
+1,183
+14% +$39.1K ﹤0.01% 2707
2025
Q4 		$295K Buy
+8,227
New +$251K ﹤0.01% 2597
2025
Q3 		– Sell
-901
Closed -$361K – 3670
2025
Q2 		$361K Buy
901
+37
+4% +$431 ﹤0.01% 2475
2025
Q1 		$810K Hold
864
– – ﹤0.01% 1918
2024
Q4 		$315K Sell
864
-11,096
-93% -$114K ﹤0.01% 2515
2024
Q3 		$4.66M Buy
11,960
+2,217
+23% +$26K ﹤0.01% 1353
2024
Q2 		$3.6M Sell
9,743
-1,898,554
-99% -$34.3M ﹤0.01% 1401
2024
Q1 		$704M Buy
1,908,297
+1,746,740
+1,081% +$32.8M 0.21% 58
2023
Q4 		$60.2M Buy
+161,557
New +$2.87M 0.02% 420

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
OCM
Oaktree Capital Management Los Angeles, California $6.56B AUM 42.97% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.3B AUM 115.82% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of Montreal's INDV Position: Q1 2026 in Review

Bank of Montreal increased its Indivior Pharmaceuticals (INDV) stake by 14% in Q1 2026, buying an estimated $39.1K and bringing the position to 9,410 shares worth $287K. The position accounts for ﹤0.01% of the portfolio, ranked #2707.

Bank of Montreal first reported a position in INDV in Q4 2023 and has held it in 9 quarters since. The position peaked at $704M in Q1 2024. 289 funds tracked by Wall St. Rank hold INDV as of Q1 2026.

  • Bank of Montreal held 9,410 shares of Indivior Pharmaceuticals worth $287K as of Q1 2026.
  • Bank of Montreal bought 1,183 Indivior Pharmaceuticals shares in Q1 2026, an estimated $39.1K.
  • Indivior Pharmaceuticals made up ﹤0.01% of Bank of Montreal's portfolio in Q1 2026, its #2707 holding.
  • Bank of Montreal first reported a position in Indivior Pharmaceuticals in Q4 2023 and has held it in 9 quarters since.
  • Bank of Montreal's Indivior Pharmaceuticals position peaked at $704M in Q1 2024.
  • 289 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.